礼来Eli Lilly & Co. (LLY) 2008年年度报告「NYSE」.pdf

1、On the CoverMark Wiley is a manager at Lilly who oversees the contract manufacturing for several device products,including an insulin pen called the HumaPen Luxura HD.Although the majority of job roles that Mark has held in his 20-year career at Lilly have,in some way,touched the diabetes therapeuti

2、c area,he never could have predicted the role that a Lilly insulin product would one day play in his own life.Nor could Mark have predicted,as he packed up his laptop and left the offi ce to enjoy the 2008 holiday break with his family,that the job he would return to a week later would have such new

3、 meaning.On December 26,one day before her 14th birthday,Marks daughter,Paige,was diagnosed with type 1 diabetes.Paige had not been feeling well for awhile.She was often thirsty and had little to no appetite.Mark and his wife realized it was serious when they weighed Paige on Christmas Eve and disco

4、vered that she had lost 13 pounds since October.Upon learning Paiges diagnosis,Mark said they were shocked,but also relieved.“Finding out that Paige had diabeteswe knewwas a big deal.But we also saw it as a blessing because we knew it could be successfully treated.”Paige was admitted to a local chil

5、drens hospital,where she and her parents received what Mark describes as a“crash course on a completely new lifestyle.”But there was one particular aspect of Paiges insulin treatment that Mark did feel comfortable aboutand that was using the HumaPen Luxura HD to administer her injections.Given that

6、Mark oversees the manufacturing of this device,he was more than familiar with how the pen worked.“I guess you could say that my job just became very personal to me,”Mark said.As for Paige,she has embraced her new diagnosis and treatment regimen with a maturity and courage beyond her years.And she fe